Adverse reaction characterized by chest pain, shortness of breath, and syncope associated with verteporfin (Visudyne)

American Journal of Ophthalmology

Volumn 134, Issue 2, 2002, Pages 281-282

  Cahill, Mark T ^a   Smith, Bradley T ^a,b   Fekrat, Sharon ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; GLYCERYL TRINITRATE;

AGED; ARTICLE; CASE REPORT; DYSPNEA; HEADACHE; HEART ATRIUM FIBRILLATION; HEMOLYSIS; HUMAN; HYDRATION; INFUSION; LOW BACK PAIN; MALE; NECK PAIN; NEPHROTOXICITY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SYNCOPE; THORAX PAIN;

EID: 0036329792     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01475-7     Document Type: Article

References (6)

1. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP report 1
2. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2
3. A potentially life-threatening adverse reaction to verteporfin
4. Clinical characteristics of patients with vasovagal reactions presenting as unexplained syncope
5. Low back pain associated with streptokinase
6. Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data